Objective: To investigate the extent to which preferred drug lists and tiered formularies reflect evidence of value, as measured in published cost-utility analyses (CUAs). Methods: Using 1998-2001 ...

Objectives: In an attempt to increase the efficiency of their drug benefit policies, insurers are increasingly excluding drugs from their formularies that they deem to be of low value. Our objective ...

(Reuters) - Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from paying ...

Sheldon S. Sones, RPh, FASCP, is president of Sheldon S. Sones and Associates, a pharmacy and accreditation consulting firm based in Newington, Conn. Q: Is there a certain format that has to be used ...

During a yearslong examination of drug prices, there’s been no shortage of criticism for growing list prices, and in recent months, some companies have heard the talk and lowered their prices. Now, ...

Why the time is right for P&T committees to incorporate real-world data and ‘real-world science’ into their product assessments. The spiraling cost of prescription drugs is creating unprecedented ...

Wasteful drugs could be driving up your pharmacy benefits spend–here's how to evaluate, identify and establish a high-performance formulary. Working with your PBM to identify drugs where less ...

Although most factors in our univariate and multivariate analyses had similar directions (e.g., a positive association was found between HMO affiliation and providers' knowledge of formularies), the ...

QMedic reports a $2,000 Medicare drug cost cap starting in 2026, ensuring predictable spending and potentially avoiding ...

The Medicare Advantage Open Enrollment Period is here. Follow our step-by-step guide to compare plans, make a switch, and ...

FILE PHOTO: Employees work near brainstorming boards in Express Scripts' Technology and Innovation Lab building on Thursday, March 8, 2018, on the company's Berkeley campus. Photo by Christian Gooden, ...